Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Rivian
RIVN
|
+$68M |
| 2 |
Airbnb
ABNB
|
+$66.4M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$63.5M |
| 4 |
Lucid Motors
LCID
|
+$58.5M |
| 5 |
Sea Limited
SE
|
+$56.1M |
Top Sells
| 1 |
Apple
AAPL
|
+$560M |
| 2 |
Microsoft
MSFT
|
+$389M |
| 3 |
Amazon
AMZN
|
+$207M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$163M |
| 5 |
JD.com
JD
|
+$154M |
Sector Composition
| 1 | Technology | 29.21% |
| 2 | Healthcare | 14% |
| 3 | Consumer Discretionary | 13.69% |
| 4 | Communication Services | 10.38% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2376
MRC Global
MRC
$1.24B
| $1.18M | ﹤0.01% |
171,949
| – | – |
|
2377
Global Industrial
GIC
$1.44B
| $1.18M | ﹤0.01% |
28,900
| – | – |
|
2378
Liberty Latin America Class A
LILA
$1.51B
| $1.18M | ﹤0.01% |
101,400
-2,900
| -3% | -$33.8K |
|
2379
Holley
HLLY
$360M
| $1.18M | ﹤0.01% |
+90,900
| New | +$1.18M |
|
2380
Luxfer Holdings
LXFR
$358M
| $1.18M | ﹤0.01% |
61,100
-2,800
| -4% | -$54.1K |
|
2381
The RMR Group
RMR
$282M
| $1.18M | ﹤0.01% |
33,892
| – | – |
|
2382
Stoneridge
SRI
$229M
| $1.18M | ﹤0.01% |
59,500
| – | – |
|
2383
Relmada Therapeutics
RLMD
$53.4M
| $1.17M | ﹤0.01% |
52,000
+26,000
| +100% | +$586K |
|
2384
V2X
VVX
$1.73B
| $1.17M | ﹤0.01% |
25,600
| – | – |
|
2385
Atlanticus Holdings
ATLC
$1.02B
| $1.17M | ﹤0.01% |
+16,400
| New | +$1.17M |
|
2386
4D Molecular Therapeutics
FDMT
$324M
| $1.17M | ﹤0.01% |
53,300
+23,700
| +80% | +$520K |
|
2387
Centrus Energy
LEU
$3.99B
| $1.17M | ﹤0.01% |
+23,400
| New | +$1.17M |
|
2388
Barrett Business Services
BBSI
$1.18B
| $1.17M | ﹤0.01% |
67,600
| – | – |
|
2389
Mercantile Bank Corp
MBWM
$777M
| $1.16M | ﹤0.01% |
33,200
-1,000
| -3% | -$35K |
|
2390
Midland States Bancorp
MSBI
$385M
| $1.16M | ﹤0.01% |
46,900
| – | – |
|
2391
ANI Pharmaceuticals
ANIP
$2.11B
| $1.16M | ﹤0.01% |
25,200
+2,700
| +12% | +$124K |
|
2392
Alignment Healthcare
ALHC
$3.26B
| $1.16M | ﹤0.01% |
+82,500
| New | +$1.16M |
|
2393
MeiraGTx Holdings
MGTX
$603M
| $1.16M | ﹤0.01% |
48,800
+1,000
| +2% | +$23.8K |
|
2394
Hackett Group
HCKT
$563M
| $1.15M | ﹤0.01% |
56,092
| – | – |
|
|
SRG
2395
Seritage Growth Properties
SRG
$251M
| $1.15M | ﹤0.01% |
86,538
+1,500
| +2% | +$19.9K |
|
2396
Vuzix
VUZI
$176M
| $1.15M | ﹤0.01% |
132,400
| – | – |
|
|
NWLI
2397
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $1.15M | ﹤0.01% |
5,349
| – | – |
|
2398
Arcutis Biotherapeutics
ARQT
$2.11B
| $1.15M | ﹤0.01% |
55,200
| – | – |
|
2399
A-Mark Precious Metals
AMRK
$592M
| $1.14M | ﹤0.01% |
+37,400
| New | +$1.14M |
|
2400
Modine Manufacturing
MOD
$7.95B
| $1.14M | ﹤0.01% |
113,300
| – | – |
|